Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK…
Biotechnology
US, Berkeley Heights [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Cyclacel Pharmaceuticals, Inc. (CYCC) to it's peer group.
Peer Group
AKTX CTMX CYT RZLT IKNA OVID MBRX PULM NXTC PTIX ELYM TPST SPRO NLTX EWTX ASMB CBIO
Compare Together
Loading...